# PIMECROLIMUS
> **ANDA209345** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS UT INC · Approved 2018-12-27
## Drug
- **FDA Application Number:** ANDA209345
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PIMECROLIMUS
- **Generic name:** PIMECROLIMUS
- **Active ingredients:** PIMECROLIMUS
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS LABS UT INC
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2018-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209345)
---
*AI Analytics · CC0 1.0*